focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDci Advisors Regulatory News (DCI)

Share Price Information for Dci Advisors (DCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.70
Bid: 4.50
Ask: 4.90
Change: 0.00 (0.00%)
Spread: 0.40 (8.889%)
Open: 4.75
High: 4.80
Low: 4.70
Prev. Close: 4.70
DCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on legal actions

2 Apr 2024 15:33

RNS Number : 0228J
DCI Advisors Limited
02 April 2024
 

DCI Advisors Limited

(the "Company" or "DCI")

Update on legal actions with Dolphin Capital Partners Limited

 

2 April 2024

 

Following the Company's litigation update published on 28 March 2024, the Board of DCI has been made aware that its former manager, Dolphin Capital Partners Limited ("DCP"), has contacted a number of DCI's shareholders with claims that the litigation being pursued by DCI against DCP could prove unaffordable for DCI. Following receipt of such communication from DCP, one shareholder has even suggested that DCI obtains third party funding for its litigation against DCP.

 

The DCI board therefore wishes to advise shareholders that it started exploring litigation funding for most of its litigation against DCP from a third party in 2023, with a funding agreement signed earlier this year.

 

Further, concerning DCI's litigation against DCP and individuals associated with DCP in Greece, DCI has the funding in place to carry the litigation to its conclusion, with a maximum cost to DCI estimated at approximately €100,000. DCI's directors believe that for such a modest cost it is overwhelmingly in the best interest of shareholders as a whole that this litigation is pursued, as the advice provided to the Company is that the financial upside the Company could expect from success is currently c.€57.0 million, with the potential for this amount to increase. The litigation funding that DCI has secured will mitigate DCI's legal costs in pursuing this claim and means that DCI is well positioned to continue to their conclusion all its legal cases and claims against DCP.

 

The Board of DCI would also like to use this opportunity to respond to DCP's misleading statement that this €57.0 million claim only relates to the Amanzoe option. This is incorrect. Many different claims have been made and these are unrelated to the Amanzoe option.

 

The Directors anticipate that they will release a general update on DCI and its portfolio next week.

 

Enquiries

DCI Advisors Ltd

Nicolai Huls / Nick Paris, Managing Directors

 

nickparis@btinternet.com

+44 (0) 7738 470550

Cavendish Capital Markets (Nominated Adviser & Broker)

James King / Jonny Franklin‐Adams / Edward Whiley / Oscar Valeur‐Adu (Corporate Finance)

Pauline Tribe (Sales)

 

 

+44 (0) 20 7220 0500

FIM Capital Limited (Administrator)

Lesley Lennon / Grainne Devlin (Corporate Governance)

llennon@fim.co.im / gdevlin@fim.co.im

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDITMITMTJMBTI
Date   Source Headline
31st Oct 202210:24 amRNSHolding(s) in Company
28th Oct 202210:31 amRNSHolding(s) in Company
25th Oct 20222:30 pmRNSDirector/PDMR Shareholding
24th Oct 20229:11 amRNSDirector/PDMR Shareholding
21st Oct 20223:17 pmRNSDirector/PDMR Shareholding
20th Oct 202212:35 pmRNSDirector/PDMR Shareholding
19th Oct 20223:57 pmRNSDirector/PDMR Shareholding
18th Oct 202212:09 pmRNSResult of AGM
30th Sep 20228:46 amRNSHalf-year Report
29th Sep 20223:23 pmRNSDisposal of One&Only at Kea Island project
16th Sep 20224:41 pmRNSSecond Price Monitoring Extn
16th Sep 20224:36 pmRNSPrice Monitoring Extension
14th Sep 20224:15 pmRNSNotice of AGM
30th Jun 20229:42 amRNSAnnual Financial Report
22nd Jun 20223:52 pmRNSHolding(s) in Company
16th May 202212:18 pmRNSShareholder Communications Letter
22nd Dec 202112:09 pmRNSResult of Extraordinary General Meeting
2nd Dec 20217:00 amRNSNotice of EGM
26th Nov 20217:00 amRNSChange of Adviser
27th Sep 20217:00 amRNSHalf Year Results and Trading Update
19th Jul 20217:50 amRNSDrawdown of 2nd tranche of EUR15m loan facility
19th Jul 20217:00 amRNSDrawdown of 2nd tranche of EUR15m loan facility
1st Jul 20217:05 amRNSGovernance Changes and Strategic Review
1st Jul 20217:00 amRNSDirectorate Changes
30th Jun 20217:00 amRNSAnnual Financial Report
7th Jun 20217:00 amRNSFinal Results
6th May 20212:26 pmRNSHolding(s) in Company
31st Mar 202111:52 amRNSHolding(s) in Company
5th Mar 20217:00 amRNSHolding(s) in Company
7th Jan 202110:18 amRNSHolding(s) in Company
22nd Dec 20209:19 amRNSHolding(s) in Company
15th Oct 20204:27 pmRNSUpdate on Cyprus Citizenship Investment Programme
12th Oct 20209:42 amRNSHolding(s) in Company
12th Oct 20209:38 amRNSHolding(s) in Company
8th Oct 20202:32 pmRNSHolding(s) in Company
29th Sep 20207:00 amRNSHalf-year Report
2nd Sep 202011:05 amRNSSecond Price Monitoring Extn
2nd Sep 202011:00 amRNSPrice Monitoring Extension
2nd Jul 20204:19 pmRNSHolding(s) in Company
22nd Jun 20207:00 amRNSOperational Update
1st Jun 202010:29 amRNSAnnual Financial Report
28th Apr 20204:24 pmRNSHolding(s) in Company
28th Apr 20202:06 pmRNSSecond Price Monitoring Extn
28th Apr 20202:00 pmRNSPrice Monitoring Extension
28th Apr 202012:02 pmRNSHolding(s) in Company
28th Apr 202011:57 amRNSHolding(s) in Company
22nd Apr 202011:01 amRNSHolding(s) in Company
14th Apr 20202:35 pmRNSHolding(s) in Company
9th Apr 20203:30 pmRNSHolding(s) in Company
6th Apr 20207:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.